Communication Devices for People with Disabilities: Clinical Trials

16 trials of Communication Devices for People with Disabilities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 recruiting, 2 terminated, 2 unknown. 14 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable14Completed 6, Recruiting 2, Terminated 2, Unknown 2, Active not recruiting 1, Withdrawn 1
Phase 12Completed 2

Follow Communication Devices for People with Disabilities: new trials by email Literature Review of Communication Devices for People with Disabilities trials Research Report on Communication Devices for People with Disabilities

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nudging High Emergency Department Utilizers to Consider Non-emergent Healthcare Resources
Automated interactive messages, Live outreach - Emergency Service, Hospital
Not applicableCompletedGeisinger Clinic11262025-02-032026-03-13
MyChart Proxy Outreach to Parents (MyPOP)
Email, Text, Patient Portal Message - Health Technology
Not applicableRecruitingYale University52002024-10-152026-02-13
Effect of Communication Board on Functional Communication of Children With Cerebral Palsy
Communication Board, Traditional Therapy - Cerebral Palsy (CP)
Not applicableCompletedRiphah International University202024-05-062024-10-26
Mailed FIT Outreach 2022
Differentiated Box, Standard Mail, Text - Colorectal Cancer, Colon Cancer
Not applicableCompletedAbramson Cancer Center at Penn Medicine54602022-05-272024-07-24
Text My Hypertension BP Meds NOLA
Text - Hypertension
Not applicableCompletedTulane University362022-03-102023-08-21
Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People
Simulation, Text - COVID-19 Infection
Not applicableUnknownCharite University, Berlin, Germany11882022-02-032022-12-28
eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors
Health Education, Physical Activity, Health Promotion and Education: Text Messages - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Not applicableTerminatedFred Hutchinson Cancer Center202021-09-162023-07-03
Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers
E-mail, Exercise Intervention, Quality-of-Life Assessment - Caregiver, Lobectomy Patient
Not applicableWithdrawnCity of Hope Medical Center2021-05-152021-08-12
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
Computer-Assisted Intervention, Dermatoscope, Educational Intervention - Skin Carcinoma
Not applicableActive not recruitingCity of Hope Medical Center8402020-10-302026-06-25
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
Interview, Media Intervention, Questionnaire Administration - Obesity, Malignant Neoplasm
Not applicableRecruitingJonsson Comprehensive Cancer Center202020-07-012026-05-11
Flexiquit+: Web Program to Promote Smoking Cessation in Sexual and Gender Minority Young Adult Smokers
Computer-Assisted Smoking Cessation Intervention, Text Message, Handout - Tobacco Use Disorder
Phase 1CompletedFred Hutchinson Cancer Center252020-05-182020-10-05
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
Focus Group, Text Message, Best Practice - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8
Not applicableUnknownThomas Jefferson University3322018-11-072024-06-10
Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents
+ Brief ED Intervention (BI), + Text - Depressive Disorder, Violence
Not applicableCompletedRhode Island Hospital6202018-08-012026-04-29
Supporting Doctor-patient Communication in Oncology
Communication aids - Communication
Not applicableTerminatedUniversity Hospital of North Norway1802014-04-012024-03-06
Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a RAD Board
Board, No Board - Radiation Exposure to Operator
Not applicableCompletedGeisinger Clinic2652013-06-012018-10-24
Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection
GS-9669 tablets, Placebo to Match GS-9669 tablet - Hepatitis C
Phase 1CompletedGilead Sciences822011-09-012012-07-25

Conditions studied

Emergencies (2)  ·  COVID-19 (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cerebral Palsy (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Communication (1)  ·  Depression (1)  ·  Depressive Disorder (1)  ·  Hematologic Neoplasms (1)  ·  Hepatitis C (1)  ·  Hypertension (1)  ·  Lung Neoplasms (1)  ·  Motor Activity (1)  ·  Neoplasms (1)

Sponsors

City of Hope Medical Center (2)  ·  Fred Hutchinson Cancer Center (2)  ·  Geisinger Clinic (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Charite University, Berlin, Germany (1)  ·  Gilead Sciences (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Rhode Island Hospital (1)  ·  Riphah International University (1)  ·  Thomas Jefferson University (1)  ·  Tulane University (1)  ·  University Hospital of North Norway (1)  ·  Yale University (1)

Countries

United States (12)  ·  Germany (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Puerto Rico (1)

Top investigators

Ada Fenick, MD (1)  ·  Amir Goren, PhD (1)  ·  Jaimee Heffner (1)  ·  James C Blankenship, MD (1)  ·  Keith Ferdinand, MD (1)  ·  Kuang-Yi Wen, MD (1)  ·  Maimoona Ismail (1)  ·  Megan L Ranney, MD MPH (1)  ·  Odette Wegwarth, Prof. Dr. (1)  ·  Rachel Ceballos (1)  ·  Saro H Armenian (1)  ·  Shivan Mehta, MD (1)  ·  Stephen Rossi, PharmD (1)  ·  Theodore B Moore (1)

Results publications

PMID 23183437, PMID 25155588, PMID 32746799, PMID 40983155, PMID 42562001

NIH funding

P30CA015704 (2), R01CA222246 (1), R01HD093655 (1), U54GM104940 (1)